MEGHAN DZUROVCIK: Open Payments
NPI 1851945612 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 3 | $152 |
| Janssen Biotech, Inc. | 1 | $113 |
| Alexion Pharmaceuticals, Inc. | 1 | $28 |
Products named: VYVGART, TREMFYA, VYVGART HYTRULO, ULTOMIRIS.
Industry payments across IL — which companies pay providers there.
